An update on the cognitive safety of antimuscarinics in the treatment of overactive bladder

IF 3 3区医学 Q2 PHARMACOLOGY & PHARMACY

Expert Opinion on Drug Safety Pub Date : 2024-09-10 DOI:10.1080/14740338.2024.2392000

Musab M. Alghamdi, Kwang Jin Ko, Kyu-Sung Lee

引用次数: 0

Abstract

Antimuscarinics are often the first-choice medications used to treat overactive bladder (OAB), a condition that increasingly affects the aging population. However, concerns regarding their potentia...

查看原文本刊更多论文

抗惊厥药治疗膀胱过度活动症认知安全性的最新进展

抗心律失常药通常是治疗膀胱过度活动症（OAB）的首选药物。然而，人们对这些药物的药效仍存在担忧。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Opinion on Drug Safety 医学-药学

CiteScore

5.90

自引率

3.20%

发文量

审稿时长

6-12 weeks

期刊介绍： Expert Opinion on Drug Safety ranks #62 of 216 in the Pharmacology & Pharmacy category in the 2008 ISI Journal Citation Reports. Expert Opinion on Drug Safety (ISSN 1474-0338 [print], 1744-764X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of drug safety and original papers on the clinical implications of drug treatment safety issues, providing expert opinion on the scope for future development.